HUTCHMED (China) Limited
HCM
$14.20
-$0.10-0.70%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 548.51M | 575.35M | 602.20M | 616.20M | 630.20M |
| Total Other Revenue | -- | -68.52M | -137.04M | -68.52M | 0.00 |
| Total Revenue | 548.51M | 575.35M | 602.20M | 616.20M | 630.20M |
| Cost of Revenue | 484.64M | 516.54M | 548.44M | 554.71M | 560.99M |
| Gross Profit | 63.87M | 58.82M | 53.76M | 61.49M | 69.21M |
| SG&A Expenses | 103.03M | 99.88M | 96.73M | 104.82M | 112.91M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 587.67M | 604.78M | 621.90M | 647.90M | 673.91M |
| Operating Income | -39.16M | -29.43M | -19.70M | -31.70M | -43.71M |
| Income Before Tax | 521.34M | 528.19M | 535.03M | 290.20M | 45.36M |
| Income Tax Expenses | 63.61M | 65.54M | 67.47M | 37.33M | 7.19M |
| Earnings from Continuing Operations | 457.73 | 462.65 | 467.56 | 252.87 | 38.17 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -823.00K | -750.50K | -678.00K | -559.50K | -441.00K |
| Net Income | 456.91M | 461.90M | 466.88M | 252.31M | 37.73M |
| EBIT | -39.16M | -29.43M | -19.70M | -31.70M | -43.71M |
| EBITDA | -25.85M | -16.67M | -7.49M | -19.43M | -31.36M |
| EPS Basic | 0.53 | 0.54 | 0.54 | 0.29 | 0.04 |
| Normalized Basic EPS | 0.03 | 0.04 | 0.04 | 0.04 | 0.04 |
| EPS Diluted | 0.52 | 0.53 | 0.53 | 0.29 | 0.04 |
| Normalized Diluted EPS | 0.03 | 0.04 | 0.04 | 0.04 | 0.04 |
| Average Basic Shares Outstanding | 3.43B | 3.43B | 3.42B | 3.42B | 3.42B |
| Average Diluted Shares Outstanding | 3.49B | 3.49B | 3.49B | 3.49B | 3.49B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |